sglt-2i Search Results


90
Partners HealthCare System Inc canagliflozin
Canagliflozin, supplied by Partners HealthCare System Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sglt-2i/sglt2i/pm30409566-9-9-43
Average 90 stars, based on 1 article reviews
canagliflozin - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
TriNetX Inc sglt2i/glp-1 ras
Sglt2i/Glp 1 Ras, supplied by TriNetX Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sglt-2i/sglt2i/pmc11671942-138-30-7
Average 90 stars, based on 1 article reviews
sglt2i/glp-1 ras - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Ark Pharm Inc sglt2i empagliflozin empa
SGLT1 protein levels are elevated in differentiated L6 skeletal cells following <t>SGLT2i</t> but not combined SGLT1/2i. Cells were treated with vehicle, EMPA, or SOTAG after 7 days of differentiation; data represented as means ± SEM; n = 4/group; statistical analysis was conducted using one-way ANOVA; * p = 0.049.
Sglt2i Empagliflozin Empa, supplied by Ark Pharm Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sglt-2i/sglt2i+empagliflozin+empa/pmc11275186-42-7-10
Average 90 stars, based on 1 article reviews
sglt2i empagliflozin empa - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Bayer AG sglt2i
SGLT1 protein levels are elevated in differentiated L6 skeletal cells following <t>SGLT2i</t> but not combined SGLT1/2i. Cells were treated with vehicle, EMPA, or SOTAG after 7 days of differentiation; data represented as means ± SEM; n = 4/group; statistical analysis was conducted using one-way ANOVA; * p = 0.049.
Sglt2i, supplied by Bayer AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sglt-2i/sglt2i/pm39473305-59-13-40
Average 90 stars, based on 1 article reviews
sglt2i - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
AstraZeneca ltd sglt2i
Study consort diagram. IPTW = inverse probability treatment weighting; PS = propensity score; <t>SGLT2i</t> = sodium-glucose cotransporter-2 inhibitor. (Figure created in Biorender.com.)
Sglt2i, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sglt-2i/sglt2i/pmc11973685-202-13-15
Average 90 stars, based on 1 article reviews
sglt2i - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Informa UK Limited sglt2i therapy
Study consort diagram. IPTW = inverse probability treatment weighting; PS = propensity score; <t>SGLT2i</t> = sodium-glucose cotransporter-2 inhibitor. (Figure created in Biorender.com.)
Sglt2i Therapy, supplied by Informa UK Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sglt-2i/sglt2i/pm37594789-28-12-7
Average 90 stars, based on 1 article reviews
sglt2i therapy - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
InsuLine Medical Ltd sglt-2i
Study consort diagram. IPTW = inverse probability treatment weighting; PS = propensity score; <t>SGLT2i</t> = sodium-glucose cotransporter-2 inhibitor. (Figure created in Biorender.com.)
Sglt 2i, supplied by InsuLine Medical Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sglt-2i/sglt+2i/pm29159514-42-0-39
Average 90 stars, based on 1 article reviews
sglt-2i - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
SUNY Upstate Medical University sodium-glucose co-transporter 2 inhibitors
Study consort diagram. IPTW = inverse probability treatment weighting; PS = propensity score; <t>SGLT2i</t> = sodium-glucose cotransporter-2 inhibitor. (Figure created in Biorender.com.)
Sodium Glucose Co Transporter 2 Inhibitors, supplied by SUNY Upstate Medical University, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sglt-2i/sodium+glucose+co+transporter+2+inhibitors++sglt2i+/10__1136_slash_jim___2018___000974__354-2246-6-0
Average 90 stars, based on 1 article reviews
sodium-glucose co-transporter 2 inhibitors - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Anwendung GmbH sglt2i
Study consort diagram. IPTW = inverse probability treatment weighting; PS = propensity score; <t>SGLT2i</t> = sodium-glucose cotransporter-2 inhibitor. (Figure created in Biorender.com.)
Sglt2i, supplied by Anwendung GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sglt-2i/sglt2i/pmc08245922-39-12-18
Average 90 stars, based on 1 article reviews
sglt2i - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
UnitedHealth Group Inc sglt2i drug class
Study consort diagram. IPTW = inverse probability treatment weighting; PS = propensity score; <t>SGLT2i</t> = sodium-glucose cotransporter-2 inhibitor. (Figure created in Biorender.com.)
Sglt2i Drug Class, supplied by UnitedHealth Group Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sglt-2i/sglt2i+drug+class/pmc09303841-2-47-34
Average 90 stars, based on 1 article reviews
sglt2i drug class - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Explorys Inc sglt2i/glp-1 ra
Study consort diagram. IPTW = inverse probability treatment weighting; PS = propensity score; <t>SGLT2i</t> = sodium-glucose cotransporter-2 inhibitor. (Figure created in Biorender.com.)
Sglt2i/Glp 1 Ra, supplied by Explorys Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sglt-2i/sglt2i+glp+1+ra/pm33043826-17818-18-9
Average 90 stars, based on 1 article reviews
sglt2i/glp-1 ra - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
IQVIA Inc sglt2i prescriptions
Study consort diagram. IPTW = inverse probability treatment weighting; PS = propensity score; <t>SGLT2i</t> = sodium-glucose cotransporter-2 inhibitor. (Figure created in Biorender.com.)
Sglt2i Prescriptions, supplied by IQVIA Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sglt-2i/sglt2i+prescriptions/10__1161_slash_jaha__121__023811-345-8-48
Average 90 stars, based on 1 article reviews
sglt2i prescriptions - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


SGLT1 protein levels are elevated in differentiated L6 skeletal cells following SGLT2i but not combined SGLT1/2i. Cells were treated with vehicle, EMPA, or SOTAG after 7 days of differentiation; data represented as means ± SEM; n = 4/group; statistical analysis was conducted using one-way ANOVA; * p = 0.049.

Journal: Biomedicines

Article Title: Sympathetic Activation Promotes Sodium Glucose Co-Transporter-1 Protein Expression in Rodent Skeletal Muscle

doi: 10.3390/biomedicines12071456

Figure Lengend Snippet: SGLT1 protein levels are elevated in differentiated L6 skeletal cells following SGLT2i but not combined SGLT1/2i. Cells were treated with vehicle, EMPA, or SOTAG after 7 days of differentiation; data represented as means ± SEM; n = 4/group; statistical analysis was conducted using one-way ANOVA; * p = 0.049.

Article Snippet: Based on the previously published literature, the SGLT2i Empagliflozin (EMPA; Ark Pharma Scientific Limited, Wuhan, China) was used at 30 μM for in vitro purposes [ , ].

Techniques:

Study consort diagram. IPTW = inverse probability treatment weighting; PS = propensity score; SGLT2i = sodium-glucose cotransporter-2 inhibitor. (Figure created in Biorender.com.)

Journal: Heart Rhythm O2

Article Title: Sodium-glucose cotransporter-2 inhibitor use in type 2 diabetes mellitus is associated with a lower rate of atrial arrhythmias in a hospitalized real-world population

doi: 10.1016/j.hroo.2024.12.004

Figure Lengend Snippet: Study consort diagram. IPTW = inverse probability treatment weighting; PS = propensity score; SGLT2i = sodium-glucose cotransporter-2 inhibitor. (Figure created in Biorender.com.)

Article Snippet: Dr Chew has received a grant in aid for a separate study of SGLT2i from Astra Zeneca.

Techniques:

Baseline characteristics before propensity matching

Journal: Heart Rhythm O2

Article Title: Sodium-glucose cotransporter-2 inhibitor use in type 2 diabetes mellitus is associated with a lower rate of atrial arrhythmias in a hospitalized real-world population

doi: 10.1016/j.hroo.2024.12.004

Figure Lengend Snippet: Baseline characteristics before propensity matching

Article Snippet: Dr Chew has received a grant in aid for a separate study of SGLT2i from Astra Zeneca.

Techniques: Filtration, Medications

Baseline characteristics after inverse probability treatment weighting

Journal: Heart Rhythm O2

Article Title: Sodium-glucose cotransporter-2 inhibitor use in type 2 diabetes mellitus is associated with a lower rate of atrial arrhythmias in a hospitalized real-world population

doi: 10.1016/j.hroo.2024.12.004

Figure Lengend Snippet: Baseline characteristics after inverse probability treatment weighting

Article Snippet: Dr Chew has received a grant in aid for a separate study of SGLT2i from Astra Zeneca.

Techniques: Filtration, Medications

HRs of incidence of cardiac arrhythmias associated with  SGLT2i  therapy

Journal: Heart Rhythm O2

Article Title: Sodium-glucose cotransporter-2 inhibitor use in type 2 diabetes mellitus is associated with a lower rate of atrial arrhythmias in a hospitalized real-world population

doi: 10.1016/j.hroo.2024.12.004

Figure Lengend Snippet: HRs of incidence of cardiac arrhythmias associated with SGLT2i therapy

Article Snippet: Dr Chew has received a grant in aid for a separate study of SGLT2i from Astra Zeneca.

Techniques:

Kaplan-Meier curve showing cumulative incidence of atrial arrhythmias (percentage) over 2 years of follow up. Blue line indicates no sodium-glucose cotransporter-2 inhibitor (SGLT2i) use. Red line indicates SGLT2i use. Hazard ratio (HR) associated 0.17, 95% confidence interval (CI) 0.07–0.41, P <.001.

Journal: Heart Rhythm O2

Article Title: Sodium-glucose cotransporter-2 inhibitor use in type 2 diabetes mellitus is associated with a lower rate of atrial arrhythmias in a hospitalized real-world population

doi: 10.1016/j.hroo.2024.12.004

Figure Lengend Snippet: Kaplan-Meier curve showing cumulative incidence of atrial arrhythmias (percentage) over 2 years of follow up. Blue line indicates no sodium-glucose cotransporter-2 inhibitor (SGLT2i) use. Red line indicates SGLT2i use. Hazard ratio (HR) associated 0.17, 95% confidence interval (CI) 0.07–0.41, P <.001.

Article Snippet: Dr Chew has received a grant in aid for a separate study of SGLT2i from Astra Zeneca.

Techniques:

Cumulative incidence of atrial arrhythmias (percentage) over 2 years of follow up according to SGLT2i use. Blue line indicates no SGLT2i use. Red line indicates SGLT2i use. Left: Patients with a previous history of atrial fibrillation (HR 0.35, 95% CI 0.13–0.90, P = .030). Right: Patients without a previous history of atrial fibrillation (HR 0.07, 95% CI 0.01–0.51, P = .009). Abbreviations as in <xref ref-type=Figure 2 . " width="100%" height="100%">

Journal: Heart Rhythm O2

Article Title: Sodium-glucose cotransporter-2 inhibitor use in type 2 diabetes mellitus is associated with a lower rate of atrial arrhythmias in a hospitalized real-world population

doi: 10.1016/j.hroo.2024.12.004

Figure Lengend Snippet: Cumulative incidence of atrial arrhythmias (percentage) over 2 years of follow up according to SGLT2i use. Blue line indicates no SGLT2i use. Red line indicates SGLT2i use. Left: Patients with a previous history of atrial fibrillation (HR 0.35, 95% CI 0.13–0.90, P = .030). Right: Patients without a previous history of atrial fibrillation (HR 0.07, 95% CI 0.01–0.51, P = .009). Abbreviations as in Figure 2 .

Article Snippet: Dr Chew has received a grant in aid for a separate study of SGLT2i from Astra Zeneca.

Techniques: